CSI Market
Sign In | Register

Indivior Pharmaceuticals Inc (INDV) Annual Balance Sheets

Annual · GAAP · USD millions
Access INDV quarterly Balance Sheets →
The data below summarizes Indivior Pharmaceuticals Inc's balance sheet position from to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023)
Assets
Cash & cash equivalent195.00
Cash And Cash Equivalents0.00
Short-term Investments, Total17.00
Other Short-term Investments0.00
Cash & Short-term Investments212.00
Accounts receivable253.00
Income Taxes Receivable, Current NO2.00
Inventories75.00
Other Current Assets15.00
Prepaid Expense, Current AS34.00
Total Current Assets652.00
Equipment/Property/Plant Net107.00
Goodwill net2.00
Intangible Assets2.00
Long-term investments28.00
Deferred Tax Assets15.00
Intangible AssetsAnd Goodwill403.00
Other Current Assets-
Current Financial Assets-
Noncurrent Assets-
Operating Lease Right Of Use Asset26.00
Deferred Income Tax Assets Net323.00
Total Assets1,201.00
Liabilities
Accounts Payable and Accrued Liabilities, Current LI250.00
Accrued Liabilities, Current76.00
Estimated Litigation Liability, Current42.00
Long-term Debt, Current Maturities LO29.00
Other Liabilities, Current591.00
Accrued Income Taxes, Current TA20.00
Current Provisions0.00
Total Current Liabilities914.00
Long-term debt290.00
Total Long-term Debt290.00
Estimated Litigation Liability, Noncurrent LI52.00
Accrued Income Taxes, Noncurrent3.00
Noncurrent Provisions44.00
Contract With Customer Refund Liability Current582.00
Operating Lease Liability Current10.00
Current Lease Liabilities-
Current Tax Liabilities Current-
Operating Lease Liability Noncurrent22.00
Total Liabilities1,300.00
Stockholders' Equity
Common Stock Value62.00
Additional Paid In Capital Common Stock112.00
Retained Earnings / Accumulated Deficit-243.00
Accumulated Other Comprehensive Income-30.00
Other Equity-30.00
Common Stockholder's Equity-98.00
Total Stockholder's Equity-98.00
Liabilities & Stockholder's Equity1,201.00
4 historic quarters locked

Sign in to unlock the full Indivior Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Indivior Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: indv-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-26-012237

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License